---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-027290"
form_type: "8-K"
ticker: "BMRA"
cik: "0000073290"
company_name: "BIOMERICA INC"
filed_at: "2026-06-04T20:45:41+00:00"
generated_at: "2026-06-04T21:11:14.053641+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Biomerica sells Diagnosis stake for $500k to CEO-affiliated buyers; note forgivable on transfer

## Summary
- Biomerica sells its 6% stake in Diagnosis S.A. (78,750 shares) to CEO-affiliated entities for $500,000.
- CEO Zackary Irani directly acquires $300,000 of the shares; two LLCs buy $200,000 total.
- Payments initially made via secured promissory note at 8% interest, due in 12 months; note forgiven upon share transfer.
- Transfer requires Polish regulatory approvals expected within 30 days after closing.
- Biomerica received $52,000 dividend from Diagnosis in 2026, disclosed to buyers prior to sale.

## SEC filing metadata
- accession: 0001493152-26-027290
- form_type: 8-K
- ticker: BMRA
- cik: 0000073290
- company_name: BIOMERICA INC
- filed_at: 2026-06-04T20:45:41+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/73290/000149315226027290/0001493152-26-027290-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/73290/000149315226027290/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-027290
- JSON: https://secwatch.observer/filing/0001493152-26-027290.json
- Plain text: https://secwatch.observer/filing/0001493152-26-027290.txt

## Key facts
- Debt Financings
  BIOMERICA INC incurred loan of $500,000 with Buyers affiliated with Zackary Irani, the Company’s Chief Executive Officer at 8% per annum maturing 12 months from the Effective Date.
  - Instrument: loan
  - Principal: $500,000
  - Counterparty: Buyers affiliated with Zackary Irani, the Company’s Chief Executive Officer
  - Rate: 8% per annum
  - Maturity: 12 months from the Effective Date
  - Event: incurrence
  source text: the Buyers delivered the Purchase Price in exchange for a secured promissory term note (the “Note”) in the principal amount of $500,000. The Note bears interest at a rate of 8% per annum (the “Stated Interest Rate”) and matures 12 months from the Effective Date
  evidence_url: https://www.sec.gov/Archives/edgar/data/73290/000149315226027290/0001493152-26-027290-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.